Literature DB >> 7597198

Non-enhancing supratentorial malignant astrocytomas: MR features and possible mechanisms.

F Mihara1, Y Numaguchi, M Rothman, D Kristt, M Fiandaca, L Swallow.   

Abstract

To clarify the MR features of supratentorial malignant astrocytic gliomas that did not exhibit contrast enhancement of MR imaging, six MR parameters were evaluated in two glioblastomas and six anaplastic astrocytomas. Moderate to marked edema, mass effect, and moderate tumor heterogeneity were noted in all cases. Hemorrhage was absent in all cases. Border definition and cyst formation or necrosis were not consistent among the tumors. Histological examination demonstrated significant vascular proliferation in two cases, and mild to moderate proliferation in six. Non-enhancing malignant astrocytic gliomas are a diagnostic challenge. Analyzing perifocal edema and heterogeneity of each mass probably provides clues for a proper diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7597198

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  9 in total

1.  Value of perfusion weighted magnetic resonance imaging in the diagnosis of supratentorial anaplastic astrocytoma.

Authors:  Kyung Mi Lee; Eui Jong Kim; Geon-Ho Jahng; Bong Jin Park
Journal:  J Korean Neurosurg Soc       Date:  2014-09-30

2.  MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas.

Authors:  Xiang Liu; Wei Tian; Balasubramanya Kolar; Gabrielle A Yeaney; Xing Qiu; Mahlon D Johnson; Sven Ekholm
Journal:  Neuro Oncol       Date:  2011-02-04       Impact factor: 12.300

3.  Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.

Authors:  Sellam Karunanithi; Punit Sharma; Abhishek Kumar; Bangkim Chandra Khangembam; Guru Pada Bandopadhyaya; Rakesh Kumar; Ajit Goenka; Deepak Kumar Gupta; Arun Malhotra; Chandrasekhar Bal
Journal:  Eur Radiol       Date:  2013-04-28       Impact factor: 5.315

4.  Prediction of malignancy grading using computed tomography perfusion imaging in nonenhancing supratentorial gliomas.

Authors:  Takaaki Beppu; Makoto Sasaki; Kohsuke Kudo; Akira Kurose; Masaru Takeda; Hiroshi Kashimura; Akira Ogawa; Kuniaki Ogasawara
Journal:  J Neurooncol       Date:  2010-10-15       Impact factor: 4.130

5.  The diagnostic value of contrast enhancement on MRI in diffuse and anaplastic gliomas.

Authors:  Aleksandrs Krigers; Matthias Demetz; Astrid E Grams; Claudius Thomé; Christian F Freyschlag
Journal:  Acta Neurochir (Wien)       Date:  2022-01-11       Impact factor: 2.816

6.  Role of perfusion CT in glioma grading and comparison with conventional MR imaging features.

Authors:  S K Ellika; R Jain; S C Patel; L Scarpace; L R Schultz; J P Rock; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

7.  Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.

Authors:  H R Arvinda; C Kesavadas; P S Sarma; B Thomas; V V Radhakrishnan; A K Gupta; T R Kapilamoorthy; S Nair
Journal:  J Neurooncol       Date:  2009-02-20       Impact factor: 4.130

8.  Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.

Authors:  Deanna H Pafundi; Nadia N Laack; Ryan S Youland; Ian F Parney; Val J Lowe; Caterina Giannini; Brad J Kemp; Michael P Grams; Jonathan M Morris; Jason M Hoover; Leland S Hu; Jann N Sarkaria; Debra H Brinkmann
Journal:  Neuro Oncol       Date:  2013-03-03       Impact factor: 12.300

9.  Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors.

Authors:  Yae Won Park; Yoon Seong Choi; Sung Soo Ahn; Jong Hee Chang; Se Hoon Kim; Seung Koo Lee
Journal:  Korean J Radiol       Date:  2019-09       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.